Company / Accounts Receivable
cbdMD, Inc. Accounts Receivable History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$786.4K
FY2025
5-year range
$273.5K / $786.4K
FY2022-FY2025
Trend
+26.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Accounts Receivable has increased for 3 consecutive years, from $273,451 in FY2022 to $786,449 in FY2025.
Based on SEC 10-K filings.
$786,449 in FY2025 with a 3-year CAGR of +42.2%.
Improved from $585,345 to $786,449 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +42.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- cbdMD, Inc.'s accounts receivable has grown for 3 consecutive years.
- 3-year CAGR of +42.2%, indicating consistent growth.
- In FY2025, accounts receivable increased 26.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $786.4K | +26.5% |
| FY2024 | $621.7K | +6.2% |
| FY2023 | $585.3K | +114.1% |
| FY2022 | $273.5K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026